370 related articles for article (PubMed ID: 21826208)
1. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma.
Hara N; Yamada K; Shibata T; Osago H; Tsuchiya M
PLoS One; 2011; 6(8):e22781. PubMed ID: 21826208
[TBL] [Abstract][Full Text] [Related]
2. Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase.
Burgos ES; Schramm VL
Biochemistry; 2008 Oct; 47(42):11086-96. PubMed ID: 18823127
[TBL] [Abstract][Full Text] [Related]
3. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity.
Houry D; Raasakka A; Ferrario E; Niere M; Bifulco E; Kursula P; Ziegler M
J Struct Biol; 2023 Sep; 215(3):108004. PubMed ID: 37495196
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
5. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.
Revollo JR; Körner A; Mills KF; Satoh A; Wang T; Garten A; Dasgupta B; Sasaki Y; Wolberger C; Townsend RR; Milbrandt J; Kiess W; Imai S
Cell Metab; 2007 Nov; 6(5):363-75. PubMed ID: 17983582
[TBL] [Abstract][Full Text] [Related]
6. Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide.
Shoji S; Yamaji T; Makino H; Ishii J; Kondo A
Metab Eng; 2021 May; 65():167-177. PubMed ID: 33220420
[TBL] [Abstract][Full Text] [Related]
7. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD
Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S
J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into Xanthomonas campestris pv. campestris NAD
Xu G; Ma J; Fang Q; Peng Q; Jiao X; Hu W; Zhao Q; Kong Y; Liu F; Shi X; Tang DJ; Tang JL; Ming Z
Commun Biol; 2024 Mar; 7(1):255. PubMed ID: 38429435
[TBL] [Abstract][Full Text] [Related]
9. Boosting NAD
Gardell SJ; Hopf M; Khan A; Dispagna M; Hampton Sessions E; Falter R; Kapoor N; Brooks J; Culver J; Petucci C; Ma CT; Cohen SE; Tanaka J; Burgos ES; Hirschi JS; Smith SR; Sergienko E; Pinkerton AB
Nat Commun; 2019 Jul; 10(1):3241. PubMed ID: 31324777
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function.
Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
Diabetologia; 2011 Dec; 54(12):3083-92. PubMed ID: 21901281
[TBL] [Abstract][Full Text] [Related]
11. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
12. β-nicotinamide mononucleotide (NMN) production in Escherichia coli.
Marinescu GC; Popescu RG; Stoian G; Dinischiotu A
Sci Rep; 2018 Aug; 8(1):12278. PubMed ID: 30115969
[TBL] [Abstract][Full Text] [Related]
13. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism.
Burgos ES
Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
15. Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis.
Wang SN; Xu TY; Li WL; Miao CY
CNS Neurosci Ther; 2016 Jun; 22(6):431-9. PubMed ID: 27018006
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation.
Wang QH; Li Y; Dou DY; Wang R; Jiang TT; Wang L; Li MQ; Joshua Olatunji O; Zuo J
Int Immunopharmacol; 2021 Sep; 98():107856. PubMed ID: 34130151
[TBL] [Abstract][Full Text] [Related]
17. Biological synthesis of nicotinamide mononucleotide.
Shen Q; Zhang SJ; Xue YZ; Peng F; Cheng DY; Xue YP; Zheng YG
Biotechnol Lett; 2021 Dec; 43(12):2199-2208. PubMed ID: 34626279
[TBL] [Abstract][Full Text] [Related]
18. Metabolic engineering of Escherichia coli for biosynthesis of β-nicotinamide mononucleotide from nicotinamide.
Liu Y; Yasawong M; Yu B
Microb Biotechnol; 2021 Nov; 14(6):2581-2591. PubMed ID: 34310854
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
[TBL] [Abstract][Full Text] [Related]
20. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C
Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]